Adams Street is a global private markets investment firm with a multi-strategy approach. They focus on direct investments in venture and growth equity, primary commitments to private equity funds, and secondary transactions across various stages and geographies.
Portfolio
6
Fund Size
$65B
Top Stage
Series D
Last 12 Mo
0
Stage Distribution
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Mineralys Therapeutics, Inc. | Series B | $118M | Jun 2022 |
| Aircall | Series D | $120M | Jun 2021 |
| Mineralys Therapeutics, Inc. | Series A | $40M | Apr 2021 |
| Palvella Therapeutics, Inc. | Series C | $45M | May 2020 |
| Lyra Health | Series D | $110M | — |
| Iterable | Series E | $200M | — |
Top Co-Investors
Samsara BioCapital3 shared
Glynn Capital2 shared
DTCP2 shared
Addition1 shared
Casdin Capital1 shared
Greylock Partners1 shared
Meritech Capital1 shared
Tenaya Capital1 shared
Goldman Sachs1 shared
Swisscom Venture1 shared
Draper Esprit1 shared
Silver Lake1 shared
CRV (Charles River Ventures)1 shared
Blue Cloud Ventures1 shared
Capital One Ventures1 shared
RA Capital Management1 shared
Andera Partners1 shared
RTW Investments1 shared
Rock Springs Capital1 shared
Last updated: 1 March 2026